Millennium Health Appoints Andrew A. Lukowiak, Ph.D. as Chief Executive Officer

Lukowiak provides strong molecular diagnostics experience and leadership to Millennium Health

San Diego, CA. – February 27, 2018 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Andrew A. Lukowiak, Ph.D. as Chief Executive Officer (CEO) effective March 1, 2018. Dr. Lukowiak has nearly 20 years of management experience in molecular diagnostics and most recently served as the Chief Operating Officer (COO) and interim-CEO of a privately held precision medicine company, where he had been a part of the management team since 2013.

Read more

Millennium Health is Now Covered Under Medi-Cal

2.5 million fee-for-service patients now have access to Millennium Health’s offerings

SAN DIEGO – Jan. 29, 2018 – Millennium Health, LLC, a leading health solutions company, is proud to announce that it is now a credentialed laboratory under Medi-Cal, California’s Medicaid program. Physicians can now order the Company’s clinical services for Medi-Cal’s 2.5 million fee-for-service members. Millennium Health’s offerings approved under Medi-Cal include Millennium UDTSM and Millennium OFTSM. Also included is DxWound, a DNA test under Millennium Health’s genetics brand, CogenDx.

Read more

Millennium Health Receives Accreditation in Microbiology from the College of American Pathologists

The Company meets the most comprehensive laboratory quality standards for its DxWound test

SAN DIEGO – Jan. 23, 2018 – Millennium Health, LLC has been awarded accreditation in microbiology by the College of American Pathologists (CAP), based on results of a recent on-site inspection as part of the CAP Accreditation Program. This achievement demonstrates that the Company has attained the highest standard of excellence in laboratory practices and indicates the laboratory meets these high quality standards for the DxWound molecular microbiology test. DxWound is a product of CogenDx, the genetics brand of Millennium Health, LLC.

Read more

Millennium Health Appoints Robert H. Fish as Interim Chief Executive Officer

Mr. Fish brings more than 20 years of health care executive experience

SAN DIEGO – Dec. 14, 2017 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Robert “Bob” H. Fish as interim Chief Executive Officer (CEO), effective January 1, 2018. Mr. Fish will replace Jennifer Strickland, who is leaving the Company for another opportunity but will continue to serve in her role on Millennium Health’s Board of Directors.

Read more

Millennium Health Appoints Dave Henderson as Chief Information Officer

Henderson brings more than 20 years of information technology experience

SAN DIEGO – Nov. 13, 2017 – Millennium Health, a leading health solutions company, today announced the appointment of Dave Henderson as Chief Information Officer. In his position, Henderson will be responsible for all aspects of information technology strategy and implementation for the Company. He will be reporting directly to Michael Keane, chief financial officer, Millennium Health. Read more

U.S. Department of Veterans Affairs Awards Millennium Health with Federal Supply Schedule Contract for Pharmacogenetic Testing

SAN DIEGO Oct. 4, 2017 – In 2013, the U.S. Department of Veterans Affairs (VA) Office of Acquisition and Logistics National Acquisition Center awarded Millennium Health, a leading health solutions company, a Federal Supply Schedule (FSS) contract V797D-30178 under schedule 621II Medical Laboratory Testing and Analysis contract. Recently, VA modified Millennium’s FSS contract to add its pharmacogenetic test, Millennium PGTSM. Clinicians may now use the test to help individualize prescription medication decisions for veterans, in the areas of mental health and pain management. The Veterans Health Administration operates the nation’s largest integrated health care system with more than 1,700 health-care facilities across the country and serves nine million enrolled veterans each year.
Read more

Millennium Health Receives MAGNET GROUP Contract for Pharmacogenetic Testing and Medication Monitoring

SAN DIEGO Sept. 25, 2017 – The Mid-Atlantic Group Network of Shared Services (MAGNET GROUP), recently awarded Millennium Health, a leading health solutions company, with a contract for its pharmacogenetic test, Millennium PGTSM, and its medication monitoring services, Millennium UDTSM and Millennium OFTSM. The 9,500 health care providers within the MAGNET GROUP network now have access to these tests to help personalize treatment decisions for patients.

Read more

New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence of Non-Prescribed Fentanyl

The study demonstrates evidence of an escalating national epidemic

SAN DIEGO Sept. 20, 2017 – A new study examined urine drug test (UDT) results to measure the co-occurrence of non-prescribed fentanyl in populations of heroin-positive healthcare patients across the United States. The study revealed a 3,000 percent increase of non-prescribed fentanyl in heroin-positive patients between January 2013 and January 2017. Regionally, 5 of the 9 U.S. Census regions exhibited a dramatic increase in the co-occurrence of fentanyl use in the heroin-positive population, with New England exhibiting the greatest jump climbing from 3 percent to 76 percent. Read more

Millennium Health Announces Eugene I. Davis as Chairman of the Board and Jennifer Strickland as Chief Executive Officer

Planned transition of Ronald A. Rittenmeyer takes effect immediately

SAN DIEGO August 31, 2017 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Eugene I. Davis as Chairman of the Board and Jennifer Strickland, PharmD, BCPS, as Chief Executive Officer and Board Member. As part of a planned transition, Ronald A. Rittenmeyer steps down as Chairman and CEO and will serve in an advisory role through the end of the year.

Read more